Skip to Content

Proposed Rule

Draft Guidance; Changes To An Approved Application for Well- Characterized Therapeutic Recombinant DNA-Derived and Monoclonal Antibody Biotechnology Products; Availability

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

The full text of this document is currently available in PDF format.

The full text of this document is also available in a basic text format.